Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

National Vision Holdings (EYE) Shares Outstanding (Diluted Average) (2016 - 2026)

National Vision Holdings' Shares Outstanding (Diluted Average) history spans 11 years, with the latest figure at $80.6 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 2.52% to $80.6 million in Q1 2026 year-over-year; TTM through Jan 2026 was $80.6 million, a 2.52% increase, with the full-year FY2026 number at $80.6 million, up 2.52% from a year prior.
  • Shares Outstanding (Diluted Average) hit $80.6 million in Q1 2026 for National Vision Holdings, up from $80.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for EYE hit a ceiling of $96.1 million in Q1 2022 and a floor of $78.2 million in Q3 2023.
  • Historically, Shares Outstanding (Diluted Average) has averaged $82.8 million across 5 years, with a median of $79.7 million in 2025.
  • The widest YoY moves for Shares Outstanding (Diluted Average): up 16.11% in 2022, down 16.47% in 2022.
  • Tracing EYE's Shares Outstanding (Diluted Average) over 5 years: stood at $80.3 million in 2022, then decreased by 2.12% to $78.6 million in 2023, then fell by 0.01% to $78.6 million in 2024, then grew by 2.01% to $80.2 million in 2025, then grew by 0.51% to $80.6 million in 2026.
  • Business Quant data shows Shares Outstanding (Diluted Average) for EYE at $80.6 million in Q1 2026, $80.2 million in Q3 2025, and $79.7 million in Q2 2025.